{"title":"一种新的HLA-D“H”(DB6)特异性纯合子分型细胞。证明DN-1单克隆抗体9w925对HLA-D“H”决定因子具有特异性。","authors":"B. Jakobsen, P. Platz, L. Ryder, A. Svejgaard","doi":"10.1111/J.1399-0039.1986.TB01534.X","DOIUrl":null,"url":null,"abstract":"A new homozygous typing cell (HTC), SK is described. Mixed leukocyte culture (MLC) showed that SK is homozygous for HLA-D\"H\" (DB6) defined by the HTC, Herluf, and that the HLA-D typing results obtained by Herluf and SK are highly significantly correlated (Kendall's R = 0.46, p = 2.5 X 10(-5)). Both Herluf and SK are also homozygous for a new class II determinant, DN-1, defined by the monoclonal anti-B-lymphocyte antibody, 9w925, developed by Aizawa. The corresponding DN-1 antigen was present in 2.2% of 136 random, unrelated Danes and in all of six unrelated HLA-D\"H\" positive but in none of 20 HLA-D\"H\" negative individuals. Thus, there is an absolute and highly significant (p = 4 X 10(-6)) association between the cellularly defined HLA-D\"H\" determinant and the serologically defined DN-1 antigen, which strongly suggests that HLA-D\"H\" can now be detected serologically. DN-1 may be identical to DRw12 which is, however, poorly defined. The HTC-donor SK was immunized by pregnancy, and her serum contains anti-HLA-B7, which can easily be absorbed, and anti-B-lymphocyte antibodies which reacted with cells from 87.7% of 536 unrelated Danes. The reaction pattern of this serum is negatively associated with DR3, w6, and w8. This serum may define a new broad, cross-reacting antigen belonging to the same group as DRw52 and DRw53 or DQw1-w3, but it is clearly different from each of these antigens.","PeriodicalId":23105,"journal":{"name":"Tissue antigens","volume":"27 5 1","pages":"285-90"},"PeriodicalIF":0.0000,"publicationDate":"2008-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/J.1399-0039.1986.TB01534.X","citationCount":"3","resultStr":"{\"title\":\"A new homozygous typing cell with HLA-D\\\"H\\\" (DB6) specificity. Evidence that the DN-1 monoclonal antibody 9w925 is specific for the HLA-D\\\"H\\\" determinant.\",\"authors\":\"B. Jakobsen, P. Platz, L. Ryder, A. Svejgaard\",\"doi\":\"10.1111/J.1399-0039.1986.TB01534.X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A new homozygous typing cell (HTC), SK is described. Mixed leukocyte culture (MLC) showed that SK is homozygous for HLA-D\\\"H\\\" (DB6) defined by the HTC, Herluf, and that the HLA-D typing results obtained by Herluf and SK are highly significantly correlated (Kendall's R = 0.46, p = 2.5 X 10(-5)). Both Herluf and SK are also homozygous for a new class II determinant, DN-1, defined by the monoclonal anti-B-lymphocyte antibody, 9w925, developed by Aizawa. The corresponding DN-1 antigen was present in 2.2% of 136 random, unrelated Danes and in all of six unrelated HLA-D\\\"H\\\" positive but in none of 20 HLA-D\\\"H\\\" negative individuals. Thus, there is an absolute and highly significant (p = 4 X 10(-6)) association between the cellularly defined HLA-D\\\"H\\\" determinant and the serologically defined DN-1 antigen, which strongly suggests that HLA-D\\\"H\\\" can now be detected serologically. DN-1 may be identical to DRw12 which is, however, poorly defined. The HTC-donor SK was immunized by pregnancy, and her serum contains anti-HLA-B7, which can easily be absorbed, and anti-B-lymphocyte antibodies which reacted with cells from 87.7% of 536 unrelated Danes. The reaction pattern of this serum is negatively associated with DR3, w6, and w8. This serum may define a new broad, cross-reacting antigen belonging to the same group as DRw52 and DRw53 or DQw1-w3, but it is clearly different from each of these antigens.\",\"PeriodicalId\":23105,\"journal\":{\"name\":\"Tissue antigens\",\"volume\":\"27 5 1\",\"pages\":\"285-90\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-12-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/J.1399-0039.1986.TB01534.X\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tissue antigens\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/J.1399-0039.1986.TB01534.X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue antigens","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/J.1399-0039.1986.TB01534.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
摘要
描述了一种新的纯合分型细胞(HTC), SK。混合白细胞培养(MLC)结果显示,SK与HTC、Herluf定义的HLA-D“H”(DB6)为纯合子,且Herluf与SK的HLA-D分型结果高度显著相关(Kendall’s R = 0.46, p = 2.5 × 10(-5))。Herluf和SK对于新的II类决定因子DN-1也是纯合的,该决定因子由Aizawa开发的单克隆抗b淋巴细胞抗体9w925定义。在136名随机无亲缘关系的丹麦人中,有2.2%的人存在相应的DN-1抗原,6名无亲缘关系的HLA-D“H”阳性患者均存在相应的DN-1抗原,但20名HLA-D“H”阴性个体均无相应的DN-1抗原。因此,细胞定义的HLA-D“H”决定因子与血清学定义的DN-1抗原之间存在绝对且高度显著(p = 4 X 10(-6))的关联,这强烈表明HLA-D“H”现在可以通过血清学检测到。DN-1可能与DRw12相同,但DRw12的定义不明确。hc供体SK通过妊娠免疫,其血清中含有易于吸收的抗hla - b7抗体和抗b淋巴细胞抗体,与536名无亲缘关系的丹麦人中87.7%的细胞发生反应。该血清的反应模式与DR3、w6和w8呈负相关。该血清可能定义一种新的广泛的交叉反应抗原,与DRw52和DRw53或DQw1-w3属于同一组,但它与这些抗原明显不同。
A new homozygous typing cell with HLA-D"H" (DB6) specificity. Evidence that the DN-1 monoclonal antibody 9w925 is specific for the HLA-D"H" determinant.
A new homozygous typing cell (HTC), SK is described. Mixed leukocyte culture (MLC) showed that SK is homozygous for HLA-D"H" (DB6) defined by the HTC, Herluf, and that the HLA-D typing results obtained by Herluf and SK are highly significantly correlated (Kendall's R = 0.46, p = 2.5 X 10(-5)). Both Herluf and SK are also homozygous for a new class II determinant, DN-1, defined by the monoclonal anti-B-lymphocyte antibody, 9w925, developed by Aizawa. The corresponding DN-1 antigen was present in 2.2% of 136 random, unrelated Danes and in all of six unrelated HLA-D"H" positive but in none of 20 HLA-D"H" negative individuals. Thus, there is an absolute and highly significant (p = 4 X 10(-6)) association between the cellularly defined HLA-D"H" determinant and the serologically defined DN-1 antigen, which strongly suggests that HLA-D"H" can now be detected serologically. DN-1 may be identical to DRw12 which is, however, poorly defined. The HTC-donor SK was immunized by pregnancy, and her serum contains anti-HLA-B7, which can easily be absorbed, and anti-B-lymphocyte antibodies which reacted with cells from 87.7% of 536 unrelated Danes. The reaction pattern of this serum is negatively associated with DR3, w6, and w8. This serum may define a new broad, cross-reacting antigen belonging to the same group as DRw52 and DRw53 or DQw1-w3, but it is clearly different from each of these antigens.